Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com Prev Post Silver Crown Royalties Announces Closing of Final Tranche of its Non-Brokered Private Placement April 28, 2025 Next Post IBM pledges $150 billion to boost U.S. tech growth, computer manufacturing April 29, 2025 Related Posts Rio Silver to Complete 5:1 Consolidation June 28, 2025 Top 5 Canadian Mining Stocks This Week: Onyx Gold Shines with 118 Percent Gain June 28, 2025 Freegold Ventures Limited – Results of the Annual General and Special Meeting June 28, 2025